Head-to-head

Mochi Health vs Lavender Sky Health

Compared on both medications across the eight dimensions this database records. They differ on 5 of those eight. Mochi Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.

The short answer

Mochi Health is $357 a month all-in for tirzepatide; Lavender Sky Health is $377. Over twelve months that is $4,284 against $4,524. Value Scores are 55.9 and 44.1 out of 100.

Tirzepatide

Plan pages: Mochi Health plans · Lavender Sky Health plans

At 10 mg/week, Mochi Health is $357 a month all-in and Lavender Sky Health is $377 — $20 apart, or $240 across a year. Over twelve months the totals are $4,284 (billed monthly) and $4,524 (billed monthly).

Mochi Health charges a flat $278 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.

Lavender Sky Health prices tirzepatide by dose: $225 per month at 2.5 mg rising to $352 at 10 mg, a difference of $127 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.

2.557.51012.515mg/week$278$278$278$278$278$278
Mochi Health in petrol against Lavender Sky Health in graphite — all-in monthly tirzepatide cost at each dose. Second line: Lavender Sky Health.
All-in monthly tirzepatide cost at each published dose, with each program's rank among everyone publishing at that dose
DoseMochi HealthRankLavender Sky HealthRankCheaper
2.5 mg$27814/31$22512/31Lavender Sky Health by $53
5 mg$2787/17only Mochi Health publishes
7.5 mg$2787/17only Mochi Health publishes
10 mg$2788/27$35218/27Mochi Health by $74
12.5 mg$2787/17only Mochi Health publishes
15 mg$2787/17only Mochi Health publishes

The lead changes with the dose. Between 2.5 mg and 10 mg it passes to Mochi Health. Pick on the dose you expect to settle at, not the headline.

Across the 27 programs this database can rank on tirzepatide, Mochi Health sits 17 of 27 on all-in monthly cost and Lavender Sky Health sits 19. There is 1 other program priced between them. The field median is $339 and the floor is $169, so both sit above the median. Mochi Health is $188 above the cheapest tirzepatide program on record. Lavender Sky Health is $208 above the cheapest tirzepatide program on record.

LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Mochi Health undercuts it by $92, Lavender Sky Health by $72. Compounded products are not FDA approved; insurance can reverse that comparison.

Published tirzepatide rates per month on each plan term
Plan termMochi HealthLavender Sky HealthCheaper
Month to month$278$352Mochi Health by $74
Twelve months of tirzepatide if you settled at each dose
Settled doseMochi HealthLavender Sky HealthDifference
2.5 mg$4,284$3,000$1,284 apart
5 mg$4,284one side unpriced
7.5 mg$4,284one side unpriced
10 mg$4,284$4,524$240 apart
12.5 mg$4,284one side unpriced
15 mg$4,284one side unpriced

Mochi Health publishes no rate for 3-month term, 6-month term, 12-month term; Lavender Sky Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.

A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $4,284 on Mochi Health and $4,397 on Lavender Sky Health — $113 apart, and a different gap from the $240 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.

That calculation is partial: Lavender Sky Health publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.

Value Scores are 55.9 for Mochi Health and 44.1 for Lavender Sky Health, against a tirzepatide category floor of $169. Mochi Health leads by 11.8 points, and the margin comes from structure rather than price alone.

Tirzepatide Value Score components
ProgramPrice /70Evidence /15Dose /10Membership /5Total /100
Mochi Health33.112.810055.9
Lavender Sky Health31.412.80044.1

Semaglutide

Plan pages: Mochi Health plans · Lavender Sky Health plans

At 2.4 mg/week, Mochi Health is $257 a month all-in and Lavender Sky Health is $199 — $58 apart, or $696 across a year. Over twelve months the totals are $3,084 (billed monthly) and $2,388 (billed monthly).

Mochi Health charges a flat $178 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.

Lavender Sky Health charges a flat $174 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.

0.250.511.72.4mg/week$178$178$178$178$178
Mochi Health in petrol against Lavender Sky Health in graphite — all-in monthly semaglutide cost at each dose. Second line: Lavender Sky Health.

Lavender Sky Health is cheaper at every dose where both publish a price, so the lead does not change as you titrate.

Value Scores are 57.9 for Mochi Health and 58.1 for Lavender Sky Health, against a semaglutide category floor of $129. Lavender Sky Health leads by 0.2 points, driven mostly by price.

Where the two programs differ

All-in monthly

Mochi Health is cheaper month to month — $357 against $377, a gap of $20 every month, or $240 across a year if both rates hold.

Cancellation terms

Cancellation differs: Mochi Health states Cancel anytime before renewal, while Lavender Sky Health states Cancel before renewal. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.

Dose policy

Mochi Health charges one price at every dose; Lavender Sky Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.

Membership fee

Mochi Health charges a membership of $79 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.

Twelve-month cost

Over twelve months the totals are $4,284 for Mochi Health and $4,524 for Lavender Sky Health. Mochi Health is lower by $240 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.

Commitment

Commitment terms read the same on both: Month-to-month.

Evidence status

Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.

Shipping

Shipping is handled the same way by both — included in the quoted price.

What each record says

Mochi Health Official site

Mochi separates a $79/month clinical membership ($39 first month in some states) from flat medication pricing — $99/month semaglutide at any dose and $199/month tirzepatide at any dose — which makes its all-in cost easy to compute and its structure one of the most transparent in the category.

It names its compounding pharmacy — Partner 503A/503B pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Month-to-month; cancellation is Cancel anytime before renewal; availability is stated as ~50 states.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — joinmochi.com pricing + FAQ captures 2026-07-20 and 2026-08-05

Watch: Advertising leads with the medication price; the $79 membership is the number people miss. Eli Lilly named Mochi in 2025 personalized-dosing litigation; the company continues to operate.

Lavender Sky Health Official site

A small program with a modest $25/month membership; all-in maintenance figures are $174 semaglutide and $352 tirzepatide.

It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability at intake.

Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — lavenderskyhealth.com pricing capture 2026-08-05

Watch: Tirzepatide tiering widens the gap between the $200 start and the $352 maintenance figure.

What neither record tells you

Mochi Health does not publish

  • no published twelve-month tirzepatide rate
  • no published twelve-month semaglutide rate
  • no state-by-state availability list — it says ~50 states

Lavender Sky Health does not publish

  • no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
  • no published twelve-month tirzepatide rate
  • no semaglutide price at 0.5, 1, 1.7 mg per week
  • no published twelve-month semaglutide rate
  • no named compounding pharmacy

Ask Mochi Health and Lavender Sky Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.

What would change this answer

Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.

Which one suits which reader

On the lowest standing monthly rate for tirzepatide, Mochi Health Official site wins this matchup. If you expect to titrate to the top of the ladder, mochi health's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, lavender sky health carries no membership.

Both figures should be checked at the provider's own checkout before you pay. Mochi Health's tirzepatide price is provider-stated as of 2026-08-05; Lavender Sky Health's is provider-stated as of 2026-08-05.

Questions

Is Mochi Health or Lavender Sky Health cheaper for tirzepatide?

Mochi Health is cheaper on all-in monthly cost at 10 mg/week: $357 against $377, a difference of $20 a month. All-in means the medication plus every mandatory recurring fee.

What is the twelve-month cost of Mochi Health versus Lavender Sky Health?

Mochi Health works out to $4,284 across twelve months and Lavender Sky Health to $4,524, on the plan terms each publishes.

Does Mochi Health or Lavender Sky Health raise the price as the dose goes up?

Mochi Health: no, it charges one flat rate at every dose. Lavender Sky Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.

How many ways do Mochi Health and Lavender Sky Health differ?

5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.

Which of Mochi Health and Lavender Sky Health names its pharmacy?

Mochi Health does — Partner 503A/503B pharmacies. Lavender Sky Health does not, recording only Partner pharmacies, so who makes its medication cannot be independently verified.

How well evidenced are the Mochi Health and Lavender Sky Health prices?

Mochi Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Lavender Sky Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.

Which is cheaper for semaglutide?

Lavender Sky Health, at $199 a month all-in against $257 at 2.4 mg/week. The two programs do not necessarily lead on both medications.

Official sources: Mochi Health official site · Lavender Sky Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.